ResMed | RMD - Cost Of Sales

Stock Price
227.94
Daily Change
-2.76 -1.20%
Monthly
-7.76%
Yearly
8.26%
Q2 Forecast
217.34

ResMed reported $555.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Ansell USD 605.3M 351.2M Dec/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
Cooper Companies USD 376.8M 87.4M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Fisher Paykel Healthcare NZD 402.8M 15.2M Dec/2025
Globus Medical USD 290.47M 8.09M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
Masimo USD 165.2M 24.3M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Philips EUR 2.81B 417M Dec/2025
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
Sigma Healthcare AUD 1.55B 165.16M Dec/2024
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Steris USD 840.7M 26.3M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025